Erin Bohula
Boston, United States
Erin Bohula is an Associate Physician in Cardiovascular Medicine at Brigham and Women’s Hospital (BWH), Boston, MA, USA, an Investigator at the TIMI Study Group and an Assistant Professor at Harvard Medical School. Dr Bohula earned her DPhil in Molecular Biology from University of Oxford, Oxford, UK on a Rhodes Scholarship in molecular oncology. Following training at Harvard Medical School & BWH, she is board certified in internal medicine, cardiology, and critical care medicine. Dr Bohula studies pharmacologic interventions for cardiometabolic diseases, such as hyperlipidaemia, obesity and atherosclerotic cardiovascular disease. Her recent trial involvement includes IMPROVE-IT, FOURIER, CAMELLIA-TIMI 61, and VESALIUS-CV. As a cardiac intensivist, she was involved in creating the Critical Care Cardiology Trials Network, a North American research collaborative of cardiology critical care units (CICU) and helped to lead their inaugural RCT, COVID-PACT, studying the efficacy and safety of antithrombotic therapy in critically-ill COVID-19 patients. She has received multiple awards, including the ACC W. Proctor Harvey Young Teaching Award and the Eugene Braunwald Faculty Award. She is the vice chair of the AHA Acute Care and General Cardiology Council.
